Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
ImmunoGen, Inc. | SVP & CHIEF MEDICAL OFFICER | Common Stock | 114K | $3.38M | $29.64 | Jun 30, 2023 | Direct |
ImmunoGen, Inc. | SVP & CHIEF MEDICAL OFFICER | Restricted Stock Unit | 63.4K | $1.86M | $29.40 | Feb 3, 2023 | Direct |
ImmunoGen, Inc. | SVP & CHIEF MEDICAL OFFICER | Stock Option (right to buy) | 256K | $1.33M | $5.19 | Feb 3, 2023 | Direct |
Surrozen, Inc./DE | Director | Option (right to buy) | 1.33K | Jun 5, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
SRZN | Surrozen, Inc./DE | Jun 5, 2024 | 1 | $0 | 4 | Jun 6, 2024 | Director |
IMGN | ImmunoGen, Inc. | Jun 30, 2023 | 1 | $13.2K | 4 | Jul 5, 2023 | SVP & CHIEF MEDICAL OFFICER |
SRZN | Surrozen, Inc./DE | May 18, 2023 | 1 | $0 | 4 | May 22, 2023 | Director |
IMGN | ImmunoGen, Inc. | Feb 3, 2023 | 3 | $0 | 4 | Feb 7, 2023 | SVP & CHIEF MEDICAL OFFICER |
IMGN | ImmunoGen, Inc. | Dec 30, 2022 | 1 | $1.71K | 4 | Jan 3, 2023 | SVP & CHIEF MEDICAL OFFICER |
IMGN | ImmunoGen, Inc. | Jun 30, 2022 | 1 | $11.8K | 4 | Jul 5, 2022 | SVP & CHIEF MEDICAL OFFICER |
SRZN | Surrozen, Inc./DE | Jun 7, 2022 | 1 | $0 | 4 | Jun 9, 2022 | Director |
IMGN | ImmunoGen, Inc. | May 20, 2022 | 2 | $0 | 4 | Dec 27, 2022 | SVP & CHIEF MEDICAL OFFICER |
IMGN | ImmunoGen, Inc. | Feb 4, 2022 | 1 | $1.66M | 4 | Feb 8, 2022 | SVP & Chief Medical Officer |
IMGN | ImmunoGen, Inc. | Dec 31, 2021 | 1 | $9.86K | 4 | Jan 4, 2022 | SVP & Chief Medical Officer |
SRZN | Surrozen, Inc./DE | Aug 11, 2021 | 0 | $0 | 3 | Aug 16, 2021 | Director |
IMGN | ImmunoGen, Inc. | Jun 30, 2021 | 1 | $11.4K | 4 | Jul 2, 2021 | SVP & Chief Medical Officer |